Abiopharma

New Form SCHEDULE 13G - Ultragenyx Pharmaceutical Inc. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001167557-26-000169 <b>Size:</b> 8 KB

Mandatory Cash Dividend/ Distribution:

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001213900-26-088763 <b>Size:</b> 53 KB

Financial Statements and Related Announcement: Half Yearly Results

New Form 424B2 - UBS AG <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001839882-26-039730 <b>Size:</b> 956 KB

Financial Statements and Related Announcement: Half Yearly Results

Financial Statements and Related Announcement: Half Yearly Results

New Form SCHEDULE 13G - MONRO, INC. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001214659-26-010027 <b>Size:</b> 7 KB

New Form SCHEDULE 13G - Tonix Pharmaceuticals Holding Corp. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001167557-26-000168 <b>Size:</b> 8 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001918704-26-023626 <b>Size:</b> 433 KB

Financial Statements and Related Announcement: Half Yearly Results

New Form 424B2 - UBS AG <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001839882-26-039729 <b>Size:</b> 862 KB

New Form SCHEDULE 13G - NEWELL BRANDS INC. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001214659-26-010025 <b>Size:</b> 7 KB

Mandatory Cash Dividend/ Distribution:

Financial Statements and Related Announcement: Half Yearly Results